114 related articles for article (PubMed ID: 38331110)
1. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
[TBL] [Abstract][Full Text] [Related]
2. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
[TBL] [Abstract][Full Text] [Related]
3. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
4. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.
Kasim M; Benko E; Winkelmann A; Mrowka R; Staudacher JJ; Persson PB; Scholz H; Meier JC; Fähling M
J Biol Chem; 2014 Sep; 289(39):26973-26988. PubMed ID: 25124043
[TBL] [Abstract][Full Text] [Related]
5. High expression of HNRNPR in ESCA combined with
Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ
J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940
[TBL] [Abstract][Full Text] [Related]
6. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
7. Activation of the HNRNPA2B1/
Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR.
Zhang J; Liu B; Xu C; Ji C; Yin A; Liu Y; Yao Y; Li B; Chen T; Shen L; Wu Y
Neuro Oncol; 2024 Apr; 26(4):684-700. PubMed ID: 38070488
[TBL] [Abstract][Full Text] [Related]
9. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein hnRNPR reduces neuronal cholesterol levels by binding to and suppressing HMGCR.
Agbo J; Akinyemi AR; Li D; Zhang Q; Li X; Li W; Zhang J; Liu Q
J Integr Neurosci; 2021 Jun; 20(2):265-276. PubMed ID: 34258925
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
[No Abstract] [Full Text] [Related]
12. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
Wang W; Li S
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37877146
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2).
Li J; Neumann I; Volkmer I; Staege MS
Mol Biol Rep; 2011 Mar; 38(3):1515-21. PubMed ID: 20842449
[TBL] [Abstract][Full Text] [Related]
14. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
[TBL] [Abstract][Full Text] [Related]
15. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract][Full Text] [Related]
16. LINC00355 promotes gastric carcinogenesis by scaffolding p300 to activate CDC42 transcription and enhancing HNRNPA2B1 to stabilize CDC42 mRNA dependent on m6A.
Chen H; Xiao L; Xie G; Zhang P; Dong P; Bian B; Wang J; Zhou Y; Ma Y; Liu Y; Shen L
Mol Carcinog; 2024 Mar; 63(3):430-447. PubMed ID: 37983727
[TBL] [Abstract][Full Text] [Related]
17. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.
Reches A; Nachmani D; Berhani O; Duev-Cohen A; Shreibman D; Ophir Y; Seliger B; Mandelboim O
J Immunol; 2016 Jun; 196(12):4967-76. PubMed ID: 27194785
[TBL] [Abstract][Full Text] [Related]
18. HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.
Chen EB; Qin X; Peng K; Li Q; Tang C; Wei YC; Yu S; Gan L; Liu TS
Aging (Albany NY); 2019 Sep; 11(18):7473-7491. PubMed ID: 31527303
[TBL] [Abstract][Full Text] [Related]
19. METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma.
Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tümmler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
Nucleic Acids Res; 2024 Mar; 52(5):2648-2671. PubMed ID: 38180812
[TBL] [Abstract][Full Text] [Related]
20. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
